These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15303572

  • 1. Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole.
    Huang CN, Hsu TC, Chou HH, Tsay GJ.
    Lupus; 2004; 13(6):450-4. PubMed ID: 15303572
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN, Hsu TC, Chou HH, Tsay GJ.
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Miyamoto S.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [Abstract] [Full Text] [Related]

  • 4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 5. Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease.
    Inamo Y, Harada K.
    J Rheumatol; 1997 Mar; 24(3):576-8. PubMed ID: 9058668
    [Abstract] [Full Text] [Related]

  • 6. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T, Sakata S, Nakamura S, Matsuda M, Kojima N, Takuno H, Miura K.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul 20; 65(7):627-39. PubMed ID: 2583311
    [Abstract] [Full Text] [Related]

  • 7. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, Tominaga T, Ejima E, Yokoyama N, Eguchi K.
    Thyroid; 2000 Jul 20; 10(7):595-9. PubMed ID: 10958312
    [Abstract] [Full Text] [Related]

  • 8. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May 20; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 9. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC, Farah CS, Reis LC.
    J Clin Endocrinol Metab; 1983 Sep 20; 57(3):563-70. PubMed ID: 6192139
    [Abstract] [Full Text] [Related]

  • 10. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep 20; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
    Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N.
    Endocr J; 2002 Jun 20; 49(3):329-34. PubMed ID: 12201217
    [Abstract] [Full Text] [Related]

  • 12. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
    Kubota S.
    Intern Med; 2016 Jun 20; 55(22):3235-3237. PubMed ID: 27853063
    [Abstract] [Full Text] [Related]

  • 13. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S.
    Thyroid; 1999 Aug 20; 9(8):775-9. PubMed ID: 10482369
    [Abstract] [Full Text] [Related]

  • 14. Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease.
    Kashiwai T, Hidaka Y, Takano T, Tatsumi KI, Izumi Y, Shimaoka Y, Tada H, Takeoka K, Amino N.
    Endocr J; 2003 Feb 20; 50(1):45-9. PubMed ID: 12733708
    [Abstract] [Full Text] [Related]

  • 15. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK, Yoo WS, Kim DW, Chung HK.
    Thyroid; 2010 Sep 20; 20(9):949-54. PubMed ID: 20629556
    [Abstract] [Full Text] [Related]

  • 16. The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial.
    Wisnu W, Alwi I, Nafrialdi N, Harimurti K, Pemayun TGD, Jusman SWA, Santoso DIS, Harahap AR, Suwarto S, Subekti I.
    Front Endocrinol (Lausanne); 2021 Sep 20; 12():796194. PubMed ID: 34987480
    [Abstract] [Full Text] [Related]

  • 17. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
    Molnár I, Szentmiklósi JA, Gesztelyi R, Somogyiné-Vári É.
    Clin Exp Med; 2019 May 20; 19(2):245-254. PubMed ID: 30610492
    [Abstract] [Full Text] [Related]

  • 18. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.
    Komiya I, Yamada T, Sato A, Kouki T, Nishimori T, Takasu N.
    J Clin Endocrinol Metab; 2001 Aug 20; 86(8):3540-4. PubMed ID: 11502776
    [Abstract] [Full Text] [Related]

  • 19. Thyroid hormone autoantibodies in patients with Graves' disease: effect of anti-thyroid drug treatment.
    Ogawa T, Sakata S, Nakamura S, Takuno H, Matsui I, Sarui H, Yasuda K.
    Clin Chim Acta; 1994 Aug 20; 228(2):113-22. PubMed ID: 7988028
    [Abstract] [Full Text] [Related]

  • 20. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T, Sato A, Komiya I, Nishimori T, Ito Y, Terao A, Eto S, Tanaka Y.
    J Clin Endocrinol Metab; 2000 Aug 20; 85(8):2775-8. PubMed ID: 10946880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.